Back to search

Netherlands· NL-274e7ea0d519

Qaialdo 10 mg/ml orale suspensie

A spironolactone product containing spironolacton, registered in Netherlands by Lipomed GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC C03DA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedQaialdo 10 mg/ml orale suspensieATCC03DA01REGISTER NO.NL-274e7ea0d519PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Spironolactone is registered in 18 of 19 countries.

Countries holding a registration under ATC C03DA01 (spironolactone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Spironolactone · ATC C03DA01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of spironolactone costs, country by country.

Normalised to the WHO defined daily dose (37.5 mg), the median price runs from $0.064 in United States to $0.29 in Switzerland — a ×4.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Spironolactone · price per daily dose (37.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.29
  • IT Italy$0.17
  • FR France$0.088
  • US United States$0.064 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SPIRONOLACTON
Manufacturer
Lipomed GmbH
Country
Netherlands (NL)
ATC code
C03DA01
ATC class
Spironolactone
Defined daily dose
37.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/23/1731

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

454 interactions on record for spironolactone.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Spironolactone · interactions on record

454 records

  • 14 severe
  • 150 moderate
  • 15 minor
  • 191 info

Most severe, free to view

  • LoperamideA07DA03severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe

84 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Spironolactone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All spironolactone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aldactone, Spirobene
  • Belgium · Aldactone, Spironolactone Eg
  • Bulgaria · Спилактон, Спиронолактон Акорд
  • Cyprus · Spiro, Spirolon
  • Czechia · Spironolactone Medreg, Spironolactone Orion
  • Germany · Aldactone, Spirobeta
  • Denmark · Spirix, Spiron
  • Estonia · Spirix, Spironolactone Accord
  • Spain · Aldactone, Espironolactona Accord
  • Finland · Spirix, Spironolactone Orion
  • France · Aldactone, Spironolactone Arrow
  • United Kingdom (Northern Ireland) · Aldactone, Spironolactone Accord Healthcare
  • Greece · Aldactone
  • Croatia · Aldactone
  • Hungary · Spiron, Spironolactone Orion
  • Ireland · Aldactone, Spironolactone Accord Healthcare Ireland
  • Iceland · Spirix, Spiron
  • Italy · Aldactone, Spirolang
  • Lithuania · Spirix, Spironolactone Accord
  • Luxembourg · Aldactone, Spironolacton Ratiopharm
  • Latvia · Spirix, Spironolactone Accord
  • Malta · Aldactone, Spirolon
  • Norway · Spirix, Spironolactone Orion
  • Poland · Finospir, Spironol
  • Portugal · Aldactone, Espironolactona Alter
  • Romania · Alspiron, Spironolactonă Arena
  • Sweden · Spironolactone Accord, Spironolactone Orion
  • Slovenia · Aldactone, Spironolakton Orion
  • Slovakia · Medospir, Spironolactone Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/350d8f99-7964-4c9c-952b-d27f3b659951
GET /v1/drugs/350d8f99-7964-4c9c-952b-d27f3b659951?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/qaialdo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Spironolactone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129211",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "CITROENZUUR 1-WATER (E 330)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "MASKEERSMAAKSTOF",
    "NATRIUMBENZOAAT (E 211)",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SIMETICON EMULSIE",
    "TRIETHYLCITRAAT (E 1505)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER, GEZUIVERD",
    "WATER, GEZUIVERD",
    "XANTHAANGOM (E 415)"
  ],
  "substances": [
    "SPIRONOLACTON"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/05/26",
  "procedure_number": "EMEA/H/C/005535",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1731",
  "additional_monitoring": "N"
}

See everything about spironolactone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.